(4th version, 2022)
Posted in May, 2025
The official journal title is Korean Journal of Adult Nursing. The abbreviated title is Korean J Adult Nurs.
i. The URL address of official journal website: https://kjan.or.kr/
ii. Aims & scope statement: https://kjan.or.kr/about/index.php
KJAN is devoted to the dissemination of groundbreaking research on theory, practice, and education in the field of adult nursing. Research on other subject areas or issues that contribute to adult nursing is published at the discretion of the Editorial Board. The goal of KJAN is to contribute to health maintenance, health promotion, and disease prevention and management in adults by publishing research.
iii. Readership: This journal is published for health care professionals and administrators, including nurses, midwives, physicians, developmental specialists, public health workers, social scientists, child health educators, epidemiologists, and other health caregivers working to promote health care and welfare.
iv. Authorship criteria: https://kjan.or.kr/authors/authors.php
KJAN follows the recommendations for authorship set out by the ICMJE Authorship guidelines (http://www.icmje.org/icmje-recommendations.pdf). Authorship is attributed only to individuals who have directly participated and made significant contributions to the creation of the manuscript. Authorship should be based upon all four of the following criteria: 1) substantial contribution to the concept or design of the work, or the acquisition or analysis and interpretation of data; 2) drafting the work or revising it critically for important intellectual content; 3) final approval of the version submitted for publication; 4) accountability for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All other contributors not listed as authors should be mentioned in the acknowledgements section.
v. eISSN: 2288-338X
https://kjan.or.kr/authors/authors.php
The journal is published quarterly at the end of February, May, August, and November.
https://kjan.or.kr/authors/authors.php
All manuscripts published in KJAN are freely available through open access to read and download from any electronic link, including those found on the KJAN website (https://kjan.or.kr/) immediately and permanently after publication.
https://kjan.or.kr/authors/authors.php
All manuscripts published in KJAN are protected by copyright. The copyright and transfer rights of the digital content of the published paper and journal are owned by the KSAN. Copyright Transfer Agreement form should be submitted online at submission. All authors should print their names and sign the copyright transfer agreement.
https://kjan.or.kr/authors/authors.php
KJAN is an open-access journal. Articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives 4.0 (CC BY-NC-ND 4.0) license, which permits copying and distributing the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the KJAN.
https://kjan.or.kr/authors/authors.php
For policies on research and publication ethics that are not stated in these instructions, the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals by the International Committee of Medical Journal Editors (ICMJE) or the COPE Guidelines (https://publicationethics.org/guidance/Guidelines) can be applied. Further, all processes of handling research and publication misconduct shall follow the applicable COPE flowchart.
1) Statements of human and animal rights: Clinical research should be done in accordance with the Ethical Principles for Medical Research Involving Human Subjects, outlined in the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). Any study involving human subjects or human data must be reviewed and approved by a responsible institutional review board (IRB). Research involving meta-analyses, systematic reviews, and literature reviews does not require IRB review. For secondary data analyses, IRB review and approval for an exempt study may be required based on the decision of the Editorial Board. When necessary, the Editorial Board may request any documentation regarding ethical issues of the manuscript such as written consent or the approval of the study by the IRB. Furthermore, for studies involving human subjects, the authors must explicitly state in the paper that the research received IRB approval and was conducted in accordance with the relevant standards.
2) Statement of informed consent: Copies of written informed consent and IRB approval for clinical research should be kept. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct.
3) Originality and duplicate publication: Duplicate publication or duplicate submission is prohibited in accordance with the ICMJE recommendations (https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html). Manuscripts that have been published or are being submitted to other journal(s) should not be submitted to KJAN. Manuscripts that have been published or are currently under consideration for publication in KJAN must not be submitted to another journal. The corresponding author must obtain approval from the Editor-in-Chief of both related journals if s/he wants to reprint a published manuscript in another language.
If manuscripts have been submitted or are currently under consideration for publication in KJAN, the Editorial Board will determine the nature and degree of duplicate publication or duplicate submission for the manuscript. If a manuscript has been published in KJAN, the KSAN ethics committee will determine the nature and degree of duplication.
The corresponding author will be responsible for informing the editor regarding potential conflicts of interest for all listed authors that might influence their interpretation of data. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there is no conflict of interest, this should also be explicitly stated as "The author(s) declare(s) that there is no conflict of interest."
If reviewers or readers suspect publication malpractice, such as fabrication, falsification, salami slicing, plagiarism, or simultaneous/ duplicate publication, inappropriate changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the process of resolution will be initiated following the flowchart provided by the Committee on Publication Ethics (COPE, http://publicationethics.org/resources/flowcharts).
If a published manuscript is suspected of an ethics violation, the KSAN ethics committee, which includes the editor-in-chief of KJAN, will be convened. The procedure will be conducted in the following order: a preliminary investigation, a second investigation, and decision, in accordance with the prescribed regulations. If a published manuscript is determined to involve an ethics violation, members found to have violated this regulation and the general ethical principles of research will be subject to the following consequences, and other relevant matters shall be determined by the KSAN ethics committee.
1) The published manuscript will be retracted, and a public statement will be made regarding the reason for retraction.
2) Submission privileges to KJAN will be suspended for three years.
3) The retraction of the manuscript will be announced on KJAN's official website and in the printed journal.
https://kjan.or.kr/authors/authors.php
This journal follows a double-blind peer review process. Each submission will initially be assessed by the editors to determine suitability for publication in this journal. If a submission is deemed suitable, it will typically be sent to a minimum of three reviewers for an independent expert assessment of the scientific quality. The decision as to whether an article is accepted or rejected will be taken by our editors.
i. Preview: The editorial committee initially assesses each submission. The primary goal is to quickly determine which papers should not be sent for peer review and which ones should. To prevent delays for authors who may wish to submit their work elsewhere, papers that do not meet basic standards or are unlikely to be published, even with a favorable peer review—such as those with insufficient novel contributions or unclear relevance to the field—may be rejected at this stage.
ii. Peer-review process: There is a two-week peer review period, and the first deci¬sion is made after the evaluation is finished. Following the review, the Editorial Board will decide between the options: acceptable options include minor revision, major revision, or rejection. The Editorial Board may request authors to make changes to the manuscript in response to reviewers’ comments. If the author deems a reviewer’s opinion to be unacceptable or thinks that a reviewer has misinterpreted the data, a reasonable explanation should be provided. Authors should try their best to comply with any requests made by the reviewers to modify the manuscript.
After making changes to the manuscript, the author should upload the updated files along with a response to each reviewer’s comment. Revisions from the author must be finished within 14 days of the request. The Editorial Board will inform the author if it is not received by the deadline. The author should discuss an extension with the Editorial Board if they want to prolong the revision window past 14 days. The Editorial Board may consider further review upon the author’s request. The Editorial Board will ultimately decide whether to approve the submitted manuscript for publication and may, if necessary, ask for additional alterations, edits, and deletions to the article text. Statistical editing is also done if a statistician needs to review the data professionally.
The editor-in-chief of KJAN will make the final decision regarding the manuscript’s publication based on the reviewers’ comments and the scientific merits of the manuscript. Any potential or existing conflict and issues in the manuscript must be discussed in detail with the Editorial Board.
iii. Appeals of decisions: Any appeals against the editorial decision must be made within 2 weeks of the date of the decision letter. Authors who wish to appeal against a deci¬sion should contact the Editor-in-Chief, explaining in de¬tail the reasons for the appeal. All appeals will be dis¬cussed with at least one other associate editor. If consensus cannot be reached thereby, an appeal will be discussed at a full editorial meeting. The process of handling complaints and appeals follows the guidelines of COPE available from (https://publicationethics.org/appeals). KJAN does not consider second appeals.
https://kjan.or.kr/authors/authors.php
Korean Journal of Adult Nursing is freely accessible online to read, download, and share, immediately upon publication from https://kjan.or.kr according to the Creative Commons License (https://creativecommons.org/licenses/by/4.0/). The copyright, including the right of online transmission, is owned by the Korean Society of Adult Nursing.
i. Information about the ownership of the journal: This journal is owned by the publisher, the Korean Society of Adult Nursing (https://www.ana.or.kr/).
ii. Management team of the journal: https://kjan.or.kr/about/editorial.php
https://kjan.or.kr/about/editorial.php
The governing body is the journal’s editorial board.
https://kjan.or.kr/about/editorial.php
i. Editorial team: https://kjan.or.kr/about/editorial.php Editorial team is available from Editorial Board page at the front part of the journal.
ii. Contact information: https://kjan.or.kr/about/contact.php
https://kjan.or.kr/authors/authors.php
An article processing charge (APC) of 600 USD (600,000 Korean Won) per article is requested to the corresponding author upon acceptance.
The revenue sources of the journal are support from the publisher (the Korean Society of Adult Nursing).
Korean Journal of Adult Nursing currently does not operate advertised products or services.
Journal propagation is done through the journal’s website. Invitations to submit a manuscript are usually offered to presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope..
E-SUBMISSION
